Literature DB >> 24327345

Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).

Wojciech Kaczmarski1, Madhabi Barua, Bozena Mazur-Kolecka, Janusz Frackowiak, Wieslaw Dowjat, Pankaj Mehta, David Bolton, Yu-Wen Hwang, Ausma Rabe, Giorgio Albertini, Jerzy Wegiel.   

Abstract

The gene encoding dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is located within the Down syndrome (DS) critical region of chromosome 21. DYRK1A interacts with a plethora of substrates in the cytosol, cytoskeleton, and nucleus. Its overexpression is a contributing factor to the developmental alterations and age-associated pathology observed in DS. We hypothesized that the intracellular distribution of DYRK1A and cell-compartment-specific functions are associated with DYRK1A posttranslational modifications. Fractionation showed that, in both human and mouse brain, almost 80% of DYRK1A was associated with the cytoskeleton, and the remaining DYRK1A was present in the cytosolic and nuclear fractions. Coimmunoprecipitation revealed that DYRK1A in the brain cytoskeleton fraction forms complexes with filamentous actin, neurofilaments, and tubulin. Two-dimensional gel analysis of the fractions revealed DYRK1A with distinct isoelectric points: 5.5-6.5 in the nucleus, 7.2-8.2 in the cytoskeleton, and 8.7 in the cytosol. Phosphate-affinity gel electrophoresis demonstrated several bands of DYRK1A with different mobility shifts for nuclear, cytoskeletal, and cytosolic DYRK1A, indicating modification by phosphorylation. Mass spectrometry analysis disclosed one phosphorylated site in the cytosolic DYRK1A and multiple phosphorylated residues in the cytoskeletal DYRK1A, including two not previously described. This study supports the hypothesis that intracellular distribution and compartment-specific functions of DYRK1A may depend on its phosphorylation pattern.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DYRK1A; brain; cytoskeleton; nucleus; phosphorylation

Mesh:

Substances:

Year:  2013        PMID: 24327345      PMCID: PMC3951420          DOI: 10.1002/jnr.23279

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  52 in total

1.  A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.

Authors:  Yousang Gwack; Sonia Sharma; Julie Nardone; Bogdan Tanasa; Alina Iuga; Sonal Srikanth; Heidi Okamura; Diana Bolton; Stefan Feske; Patrick G Hogan; Anjana Rao
Journal:  Nature       Date:  2006-03-01       Impact factor: 49.962

2.  Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.

Authors:  Noriko Murakami; Wen Xie; Renne Chen Lu; Mo-Chou Chen-Hwang; Andrzej Wieraszko; Yu Wen Hwang
Journal:  J Biol Chem       Date:  2006-05-29       Impact factor: 5.157

3.  Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome.

Authors:  J Guimera; C Casas; X Estivill; M Pritchard
Journal:  Genomics       Date:  1999-05-01       Impact factor: 5.736

4.  Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification.

Authors:  Kenneth M Humphries; Michael S Deal; Susan S Taylor
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

5.  Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways.

Authors:  Tatyana Adayev; Mo-Chou Chen-Hwang; Noriko Murakami; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

6.  The murine Dyrk protein maps to chromosome 16, localizes to the nucleus, and can form multimers.

Authors:  W J Song; S H Chung; D M Kurnit
Journal:  Biochem Biophys Res Commun       Date:  1997-02-24       Impact factor: 3.575

7.  Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases.

Authors:  W Becker; Y Weber; K Wetzel; K Eirmbter; F J Tejedor; H G Joost
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

8.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

Authors:  Joseph R Arron; Monte M Winslow; Alberto Polleri; Ching-Pin Chang; Hai Wu; Xin Gao; Joel R Neilson; Lei Chen; Jeremy J Heit; Seung K Kim; Nobuyuki Yamasaki; Tsuyoshi Miyakawa; Uta Francke; Isabella A Graef; Gerald R Crabtree
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

9.  Dephosphorylation specificities of protein phosphatase for cardiac troponin I, troponin T, and sites within troponin T.

Authors:  Nathan M Jideama; Brian H Crawford; A K M A Hussain; Robert L Raynor
Journal:  Int J Biol Sci       Date:  2006-03-01       Impact factor: 6.580

10.  The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site.

Authors:  Katrin de Graaf; Hanna Czajkowska; Sabine Rottmann; Len C Packman; Richard Lilischkis; Bernhard Lüscher; Walter Becker
Journal:  BMC Biochem       Date:  2006-03-02       Impact factor: 4.059

View more
  10 in total

1.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

2.  DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors.

Authors:  Cristina Grau; Krisztina Arató; José M Fernández-Fernández; Aitana Valderrama; Carlos Sindreu; Cristina Fillat; Isidre Ferrer; Susana de la Luna; Xavier Altafaj
Journal:  Front Cell Neurosci       Date:  2014-10-17       Impact factor: 5.505

Review 3.  DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.

Authors:  Arnaud Duchon; Yann Herault
Journal:  Front Behav Neurosci       Date:  2016-06-03       Impact factor: 3.558

4.  Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism.

Authors:  Esti Wahyu Widowati; Sabrina Ernst; Ralf Hausmann; Gerhard Müller-Newen; Walter Becker
Journal:  Biol Open       Date:  2018-04-26       Impact factor: 2.422

5.  Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.

Authors:  Karol Dowjat; Tatyana Adayev; Urszula Wojda; Katarzyna Brzozowska; Anna Barczak; Tomasz Gabryelewicz; Yu-Wen Hwang
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome.

Authors:  Helin Atas-Ozcan; Véronique Brault; Arnaud Duchon; Yann Herault
Journal:  Genes (Basel)       Date:  2021-11-20       Impact factor: 4.096

7.  CsPOM1, a DYRK Family Kinase, Plays Diverse Roles in Fungal Development, Virulence, and Stress Tolerance in the Anthracnose Pathogen Colletotrichum scovillei.

Authors:  Jong-Hwan Shin; Hee-Yeong Kim; Teng Fu; Kwang-Ho Lee; Kyoung Su Kim
Journal:  Front Cell Infect Microbiol       Date:  2022-04-26       Impact factor: 6.073

8.  K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR.

Authors:  Pengshan Zhang; Zhe Zhang; Yinkun Fu; Ying Zhang; Michael P Washburn; Laurence Florens; Min Wu; Chen Huang; Zhaoyuan Hou; Man Mohan
Journal:  Cell Death Dis       Date:  2021-06-11       Impact factor: 8.469

Review 9.  Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.

Authors:  Rut Mazón-Cabrera; Patrick Vandormael; Veerle Somers
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

10.  A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival.

Authors:  Maribel Lara-Chica; Alejandro Correa-Sáez; Rafael Jiménez-Izquierdo; Martín Garrido-Rodríguez; Francisco J Ponce; Rita Moreno; Kimberley Morrison; Chiara Di Vona; Krisztina Arató; Carla Jiménez-Jiménez; Rosario Morrugares; M Lienhard Schmitz; Susana de la Luna; Laureano de la Vega; Marco A Calzado
Journal:  Cell Death Differ       Date:  2021-08-06       Impact factor: 15.828

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.